You are Trying to View a Premium Article

Daily News You Can't Find Anywhere Else

Pfizer/Mylan Merger Creates Generic Drugs Giant


Industry Segment: Pharmaceutical & Biotech | Word Count: 685 Words

GALWAY, IRELAND--August 5, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Pfizer (NYSE:PFE) (New York, New York) and Mylan (NASDAQ:MYL) (Canonsburg, Pennsylvania) are to merge their off-patent drugs businesses into a new company that will have estimated revenues of $19 billion to $20 billion to become the world's largest generic drugmaker.

Within this article: Details merger, value of new company, leading products, markets

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type: Pricing Help?

  • Pay-Per-Article - $3.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00